Microbiome Testing in 2026: Viome vs. Ombre vs. ZOE Compared

Microbiome testing has moved from a research curiosity to a consumer product you can order on Amazon. The pitch is appealing: send in a stool sample, get back a detailed map of your gut bacteria, and receive personalized recommendations for diet and supplements. Three platforms dominate the space — Viome, Ombre (formerly Thryve), and ZOE — and they differ meaningfully in methodology, cost, and what they actually tell you.

The problem is that most reviews of these services evaluate them the way you'd evaluate a gadget: how nice is the app, how fast were the results. The more important questions are about analytical methodology, scientific validity, and whether the recommendations change outcomes. Those are harder questions, and the answers are less flattering.

What Microbiome Testing Actually Measures

Before comparing platforms, it's worth understanding what these tests do and don't do.

A microbiome test analyzes a stool sample to identify which microorganisms are present in your gut and in what relative abundances. The two primary technologies are:

16S rRNA gene sequencing

This method sequences a specific gene (16S ribosomal RNA) that's present in all bacteria. Different bacterial species have slightly different 16S sequences, which allows identification down to the genus level and sometimes the species level. It's cheaper and faster but less granular — it tells you "what's there" but not "what it's doing."

Metatranscriptomics / shotgun metagenomics

These methods sequence all genetic material in a sample (metagenomics) or all actively expressed RNA (metatranscriptomics). They provide species-level and sometimes strain-level identification, plus functional information — which metabolic pathways are active, which genes are being expressed. More expensive and complex to interpret, but significantly more informative.

The Three Platforms

Viome

Viome uses metatranscriptomic analysis — it sequences the RNA in your sample to measure gene expression activity, not just bacterial DNA presence. This is the most technically sophisticated approach among the consumer platforms.

What you get:

• Microbial species identification plus functional activity scoring
• Health scores for inflammatory activity, metabolic fitness, digestive efficiency, and more
• Personalized food recommendations (foods to enjoy, minimize, and avoid)
• Supplement recommendations (Viome sells its own supplement formulations based on results)
• Retesting recommended every 6 months

Methodology notes: Viome's metatranscriptomic approach is scientifically defensible — measuring what bacteria are doing is more relevant than merely knowing which ones are present. However, the platform's recommendation engine is proprietary, and the algorithms translating microbial activity data into specific food and supplement recommendations have not been published in peer-reviewed journals.

Ombre (formerly Thryve)

Ombre uses 16S rRNA sequencing — the simpler, less expensive methodology. It identifies bacteria at the genus and species level but doesn't provide functional pathway information.

What you get:

• Bacterial diversity scores
• Relative abundance of key bacterial groups
• Comparison to a "healthy reference" population
• Probiotic strain recommendations matched to your profile
• Ombre sells matched probiotic formulations based on results

Methodology notes: 16S sequencing is a well-validated technique, but it provides less resolution than metagenomics or metatranscriptomics. Two people with identical 16S profiles could have very different microbiome functional activity. The "healthy reference" comparison is also problematic — there's no universally agreed-upon "healthy microbiome" composition.

ZOE

ZOE takes a multi-modal approach: stool sample analysis (shotgun metagenomics) plus a continuous glucose monitor (CGM) trial plus blood lipid testing. The combined data feeds a machine learning model that generates personalized food scores.

What you get:

• Gut microbiome composition via shotgun metagenomics
• Glucose response data from a standardized CGM trial (with test foods)
• Blood fat response measurement
• Personalized food scores (0–100 for thousands of foods)
• Ongoing dietary guidance via the ZOE app

Methodology notes: ZOE is unique in combining microbiome data with metabolic response data. The PREDICT studies (published in Nature Medicine, 2020) showed that individual glucose and lipid responses to identical foods vary enormously, and that microbiome composition partially explains this variation. ZOE's approach has more published peer-reviewed research behind it than either Viome or Ombre.

Head-to-Head Comparison

The Elephant in the Room: Reproducibility

Here's where consumer microbiome testing has a fundamental problem that none of the marketing addresses honestly.

Test-retest variability is high. A 2019 study published in mSystems sent identical stool samples to multiple commercial microbiome testing labs and found significant discordance in results — the same sample, sent to different services, produced different bacterial profiles and different recommendations. Even within the same service, split samples sometimes produced meaningfully different results.

Daily variation is real. Your microbiome composition shifts measurably from day to day based on what you ate, how you slept, whether you exercised, and dozens of other variables. A single stool sample is a snapshot of a moving target. This doesn't mean the data is useless, but it means the precision implied by detailed percentage breakdowns and specific food recommendations isn't warranted.

The "healthy reference" problem. Services that compare your results to a "healthy" population face a circular challenge: there is no consensus definition of what a healthy microbiome looks like. The Human Microbiome Project documented enormous diversity among healthy individuals. Diversity is generally considered a positive marker, but specific bacterial ratios considered "optimal" vary across studies, populations, and research groups.

Which Service Should You Choose?

The answer depends on what you're trying to get out of the test.

Choose Viome if:

• You want the deepest microbiome-specific data available to consumers
• You're interested in functional activity, not just bacterial presence
• You're comfortable with a higher price point
• You understand that the supplement recommendations are from Viome's proprietary engine, not from published clinical evidence linking your specific microbial profile to specific supplement outcomes

Choose Ombre if:

• You want a lower-cost entry point to microbiome testing
• You primarily want to understand bacterial diversity and composition
• You're interested in targeted probiotic recommendations
• You don't need functional pathway data

Choose ZOE if:

• You want actionable dietary guidance backed by your personal metabolic response data
• You care about the glucose and lipid response integration, not just microbiome composition
• You value published peer-reviewed research behind the platform's methodology
• You're willing to pay more for a multi-modal assessment (the CGM period adds genuine value)

Getting Actual Value from Microbiome Testing

Regardless of which platform you choose, here's how to extract useful information:

Track longitudinally, not cross-sectionally

A single microbiome test is an interesting curiosity. Two or three tests over 12–18 months, correlated with dietary changes, become genuinely useful data. If you increase fiber intake by 15g/day for three months and your follow-up test shows increased Bifidobacterium abundance and higher diversity scores, that's a real signal about your personal response to a dietary intervention.

Focus on diversity, not specific taxa

Microbial diversity (Shannon index, observed species count) is the most consistently associated metric with general gut health across the literature. Individual taxa ratios are less reliable and less reproducible between tests. If your diversity score increases between tests, that's meaningful regardless of which specific bacteria shifted.

Use recommendations as hypotheses, not prescriptions

When a platform tells you to eat more of food X and avoid food Y, treat this as a testable hypothesis, not a settled conclusion. Try the recommendation for 4–6 weeks while tracking relevant outcomes (digestion, energy, bloating, stool quality), then evaluate whether the change produced a measurable difference.

Combine with symptom tracking

Microbiome data becomes most useful when paired with daily symptom logs. A microbiome test showing low Lactobacillus abundance alongside a daily log showing persistent bloating after dairy creates a more complete picture than either dataset alone.

Related: Track Gut Health Improvements with Wearable Data · Gut Health Protocol: 30-Day Reset for Men · Wearable Comparison Tool

The Bottom Line

Consumer microbiome testing is a legitimate but imperfect tool. The technology works — these services do accurately identify which bacteria are in your sample. The limitations are in reproducibility, interpretation, and the gap between having microbial data and knowing what to do with it.

ZOE has the strongest published research foundation and the most holistic approach (adding metabolic response data to microbiome data). Viome has the most sophisticated sequencing methodology. Ombre offers the lowest-cost entry point. None of them can reliably tell you exactly what to eat for optimal health — that's a harder problem than any current technology solves.

The most valuable use of microbiome testing is longitudinal tracking: establishing a baseline, making a specific dietary or lifestyle intervention, retesting, and seeing what changed. A single test is interesting. A tracked experiment is informative.